June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
UVA Irradiation Activates Nrf2-Regulated Antioxidant Defense and Induces p53/Caspase3 Dependent Apoptosis in Corneal Endothelial Cells
Author Affiliations & Notes
  • Cailing Liu
    Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • Dijana Vojnovic
    Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • Irene E Kochevar
    Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Ula V Jurkunas
    Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships Cailing Liu, None; Dijana Vojnovic, None; Irene Kochevar, None; Ula Jurkunas, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4897. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Cailing Liu, Dijana Vojnovic, Irene E Kochevar, Ula V Jurkunas; UVA Irradiation Activates Nrf2-Regulated Antioxidant Defense and Induces p53/Caspase3 Dependent Apoptosis in Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4897.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Previously, we reported that Nrf2 deficiency contributes to oxidant-antioxidant imbalance, causing apoptosis in Fuchs corneal endothelial dystrophy (FECD). To mimic the oxidative stress induced by sunlight, we utilized ultraviolet-A (UVA) irradiation to challenge human corneal endothelial cells (CEC). The aim of this project is to examine whether Nrf2-regulated antioxidant defense is activated in corneal endothelium by UVA light.

Methods: An immortalized human CEC (HCECi) was exposed to a UVA lamp to induce oxidative stress. Cells grown in complete medium were pretreated in OPTI-MEM medium 24 hrs prior to UVA treatment. Post UVA treatment with a dose of 2.5, 5, 10 or 25 J/cm2, the cells were recovered in OPTI-MEM medium for 0, 3, 6, 18 or 24 hrs at 37 oC. Reactive Oxygen Species (ROS) were detected with carboxy-H2DCFDA. Cell viability was evaluated by Trypan Blue staining or by measuring the released lactate dehydrogenase in supernatants. The mRNA levels of Nrf2 target genes HO-1 and NQO1 were quantified by real-time PCR. The protein levels of phospho-p53 were examined by immunoblotting. Activated Caspase3 was examined by immunoblotting and by a fluorescence assay. At each recovery time, the non-UVA treatment was used as a control.

Results: Exposure of HCECi cells to 5 J/cm2, 10 J/cm2 and 25 J/cm2 UVA irradiation generated elevated levels of ROS production as compared to no UVA irradiation, but did not affect cell viability. At 6 hrs post irradiation, 5 J/cm2, 10 J/cm2 and 25 J/cm2 UVA irradiation led to a 1.5 to 1.6-fold increase in HO-1 mRNA as compared to controls. Similarly, 2.5 J/cm2 and 5 J/cm2 UVA irradiation caused a 1.3 to 1.5-fold increase in NQO-1 mRNA as compared to controls. Interestingly, 25 J/cm2 UVA treatment decreased NQO-1 mRNA levels at 6 hrs post irradiation. At 24 hrs post treatment, 5 J/cm2, 10 J/cm2 and 25 J/cm2 UVA exposure yielded a 1.3 to 1.8-fold increase in phospho- p53 and a 2.0 to 6.0-fold increase in activated Caspase3 levels as compared to no UVA treatment, resulting in 20-48% cell death.

Conclusions: Irradiation of HCECi cell with UVA light resulted in ROS elevation and induction of Nrf2-regulated anti-oxidant defense followed by phospho-p53 and Caspase3 activation. The initial activation of antioxidant defense exerted a cytoprotective effect which was lost with increasing recovery times and doses of UVA-induced stress.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×